Active substanceDioxomethyltetrahydropyrimidineDioxomethyltetrahydropyrimidine
Similar drugsTo uncover
  • Methyluracil
    ointment locally externally 
  • Methyluracil
    ointment locally externally 
  • Methyluracil
    suppositories rect. 
  • Methyluracil
    pills inwards 
    UPDATE OF PFC, CJSC     Russia
  • Methyluracil
    ointment externally 
    GREEN DUBRAVA, CJSC     Russia
  • Methyluracil
    ointment locally externally 
  • Methyluracil
    ointment locally externally 
  • Methyluracil
    suppositories rect. 
    ALTAYVITAMINS, CJSC     Russia
  • Methyluracil
    suppositories rect. 
    YUZHFARM, LLC     Russia
  • Methyluracil-ACOS
    ointment externally 
    SYNTHESIS, OJSC     Russia
  • Metouracol
    sponge externally 
  • Oxolin
    ointment externally 
  • Stisamet®
    ointment locally externally 
  • Dosage form: & nbspointment for topical and topical application
    Composition:

    100 g of ointment contains:

    active substance: dioxomethyltetrahydropyrimidine 10 g;

    Excipients: Vaseline medical - 45 g, lanolin anhydrous - 31.5 g, water for injection - up to 100 g.

    Description:Ointment from pale yellow to pale cream color.
    Pharmacotherapeutic group:Stimulator of tissue repair
    ATX: & nbsp

    D.11.A.X   Other preparations for the treatment of skin diseases

    L.03.A.X   Other immunostimulants

    Pharmacodynamics:

    Has anabolic and anti-catabolic activity. Has anti-inflammatory effect. Normalizing the nucleic acid metabolism, accelerates the processes of cellular regeneration in wounds, accelerates the growth and granulation maturation of the tissue and epithelization. With external application has photoprotective properties.

    Indications:

    Sluggish wounds, burns (thermal, chemical, radiation), bullous dermatitis. Methyluracil can be used prophylactically to prevent skin reactions during irradiation of tumors with low radiosensitivity, decrease in radio-epithelium and late fusion of the walls (occlusions) of the vagina - in the case of radiotherapy of neoplasms of the genitals.

    Contraindications:Hypersensitivity to the drug, the redundancy of granulations, children's age.
    Carefully:

    Pregnancy and lactation.

    Pregnancy and lactation:

    The use of the drug during pregnancy and lactation is possible only if the intended benefit to the mother exceeds the potential risk to the fetus and the baby.

    Dosing and Administration:

    Outwardly. Locally.

    For the treatment of acute bullous radiation dermatitis, burns, wounds and ulcers, the drug is used externally, which is compatible with external applications of sulfonamides, antibiotics and antiseptic agents. The ointment is applied to the damaged areas with a thin layer in an amount of 5-20 g daily for 15-30 days.

    In the case of radiotherapy of neoplasms of the genitals for the prevention and treatment of radio-epithelium, ointment is used in loose tampons. The course of treatment is individual.
    Side effects:Allergic reactions in the form of itching, hyperemia and short-term burning.
    Interaction:

    The drug is compatible with external applications of antibacterial and antiseptic agents.

    Form release / dosage:

    Ointment for topical and topical application 10%.

    Packaging:

    25 g in aluminum tubes.

    Each tube together with the instruction for use is placed in a pack of cardboard.

    Storage conditions:

    In a dry place, at a temperature not exceeding 15 ° ะก.

    Keep out of the reach of children.

    Shelf life:

    3 years and 6 months.

    Do not use after the expiry date printed on the label!

    Terms of leave from pharmacies:Without recipe
    Registration number:LSR-000856/10
    Date of registration:10.02.2010 / 21.06.2017
    Expiration Date:Unlimited
    The owner of the registration certificate:Promomed Rus, Open CompanyPromomed Rus, Open Company Russia
    Manufacturer: & nbsp
    Information update date: & nbsp08.05.2018
    Illustrated instructions
      Instructions
      Up